Triple receptor agonist
Retatrutide
20 mg
20 mg / 3 ml prefilled pen for subcutaneous use.
- Presentation
- 20 mg/3 ml (6.6 mg/ml) prefilled pen
- Pharmaceutical form
- Solution for injection
- Route of administration
- Subcutaneous
- Storage
- 2 to 8 °C. Do not freeze. Protect from light.
For clinical, packaging or regulatory enquiries, contact our medical information team.
Make an enquiryProduct information
Overview
Retatrutide 20 mg is presented in a prefilled pen with a 3 ml reservoir at 6.6 mg/ml, finished with a green terminal cap for strength differentiation.
Presentation details
- Green cap strength differentiation
- Single-patient use presentation
- Serialised carton with verification panel
Specification
- Active ingredient
- Retatrutide
- Class
- GIP/GLP 1/glucagon receptor agonist
- Concentration
- 6.6 mg/ml
- Fill volume
- 3 ml
- Device
- Multi-dose prefilled pen
- Pack
- 1 pen per carton
